1. Initial combination therapy with metformin, pioglitazone and exenatide is more effective than sequential add‐on therapy in subjects with new‐onset diabetes. Results from the Efficacy and Durability of Initial Combination Therapy for Type 2 Diabetes (EDICT): a randomized trial. Issue 3 (7th January 2015) Authors: Abdul‐Ghani, M. A.; Puckett, C.; Triplitt, C.; Maggs, D.; Adams, J.; Cersosimo, E.; DeFronzo, R. A Journal: Diabetes, obesity & metabolism Issue: Volume 17:Issue 3(2015:Mar.) Page Start: 268 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗